The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
According to the estimates by IMARC Group, the India dietary supplements market is expected to witness a CAGR of 14% during 2022-2027.
Sudden outbreak of the COVID-19 pandemic had led to the increasing consumption of dietary supplements for improving the immune system to combat coronavirus infection, thereby augmenting the market growth in India.
The rising consumer awareness towards the importance of proper nutritional intake, coupled with with the changing food habits are some of the key drivers for the India dietary supplements market.
Several upgradations in the healthcare infrastructures, along with the improving distribution networks in the country, represents some of the key trends in the India dietary supplements market.
On the basis of the product type, the market has been bifurcated into vitamin and mineral dietary supplements, herbal dietary supplements, protein dietary supplements, and others. Amongst these, vitamin and mineral dietary supplements account for the largest market share.
On the basis of the form, the market has been divided into tablets, capsules, powders, liquids, soft gels, and gel caps. At present, tablets exhibit a clear dominance in the market.
On the basis of the distribution channel, the market has been segregated into pharmacies and drug stores, supermarkets and hypermarkets, online channels, and others. Amongst these, pharmacies and drug stores hold largest market share.
The key companies in the India dietary supplements market are Amway India Enterprises Private Limited, Herbalife International India Private Limited, Dabur India Limited, Abbott India Limited, Kraft Heinz India Private Limited, Himalaya Drug Company, Sun Pharmaceutical Industries Limited, GlaxoSmithKline Consumer Healthcare Limited, Danone Nutricia International Private Limited, Patanjali Ayurved Limited, etc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at